Investor Relations
Welcome to Alzinova AB’s IR pages.
Alzinova AB is a company specializing in the treatment of Alzheimer’s disease – one of our major health scourges, without effective treatment options.
Latest press releases
- 2021-08-26 | Regulatory Alzinova AB interim report January – June 2021
- 2021-07-26 | Regulatory Alzinova presents preclinical data on Alzheimer disease candidates at the AAIC conference
Latest news
- 2021-09-20 21 September - World Alzheimer’s Day
- 2021-09-17 Alzinova at Redeye Investor Forum Online